The novel cognitive enhancer st101 enhances acetylcholine release in mouse dorsal hippocampus through t-type voltage-gated calcium channel stimulation

Journal of Pharmacological Sciences

Volumn 121, Issue 3, 2013, Pages 212-226

  Yamamoto, Yui ^a   Shioda, Norifumi ^a   Han, Feng ^b   Moriguchi, Shigeki ^a   Fukunaga, Kohji ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Acetylcholine; Learning and memory; Olfactory bulbectomized; ST101; T type voltage gated calcium channel (VGCC)

Indexed keywords

ACETYLCHOLINE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II ALPHA; CALCIUM CHANNEL T TYPE; GLUTAMATE RECEPTOR 1; MITOGEN ACTIVATED PROTEIN KINASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; NOOTROPIC AGENT; PROTEIN KINASE C ALPHA; PROTEIN SERINE THREONINE KINASE; SPIRO (IMIDAZO[1,2 A]PYRIDINE 3,2 INDAN) 2(3H)ONE; ST 101; SYNAPSIN I; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

ACETYLCHOLINE BRAIN LEVEL; ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; IN VIVO STUDY; MALE; MEMORY; MOUSE; NONHUMAN; SINGLE DRUG DOSE; SPATIAL MEMORY; WORKING MEMORY;

EID: 84877293743     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.12233FP     Document Type: Article

References (39)

1. Yamaguchi Y, Miyashita H, Tsunekawa H, Mouri A, Kim HC, Saito K, et al. Effects of a novel cognitive enhancer, spiro[imidazo-[1,2-A]pyridine-3,2-indan]- 2(3H)-one (ST101), on learning impairments induced by amyloid-beta1-40 in the rat. J Pharmacol Exp Ther. 2006;317:1079-1087. (Pubitemid 43764111)
2. Ito Y, Takuma K, Mizoguchi H, Nagai T, Yamada K. A novel azaindolizinone derivative ST101 (spiro[imidazo[1,2-A]pyridine- 3,2-indan]-2(3H)-one) improves methamphetamine-induced impairment of recognition memory in mice by activating extracellular signal-regulated kinase 1/2. J Pharmacol Exp Ther. 2007; 320:819-827. (Pubitemid 46147964)
3. Yamamoto T, Jin J, Watanabe S. Characteristics of memory dysfunction in olfactory bulbectomized rats and the effects of cholinergic drugs. Behav Brain Res. 1997;83:57-62. (Pubitemid 27086615)
4. Hozumi S, Nakagawasai O, Tan-No K, Niijima F, Yamadera F, Murata A, et al. Characteristics of changes in cholinergic function and impairment of learning and memory-related behavior induced by olfactory bulbectomy. Behav Brain Res. 2003;138: 9-15. (Pubitemid 35463233)
5. Harkin A, Kelly JP, Leonard BE. A review of the relevance and validity of olfactory bulbectomy as a model of depression. Clin Neurosci Res. 2003;3:253-262. (Pubitemid 37474034)
6. Han F, Shioda N, Moriguchi S, Qin ZH, Fukunaga K. The vanadium (IV) compound rescues septo-hippocampal cholinergic neurons from neurodegeneration in olfactory bulbectomized mice. Neuroscience. 2008;151:671-679.
7. Han F, Shioda N, Moriguchi S, Yamamoto Y, Raie AY, Yamaguchi Y, et al. Spiro[imidazo[1,2-A]pyridine-3,2-indan]- 2(3H)-one (ZSET1446/ST101) treatment rescues olfactory bulbectomy-induced memory impairment by activating Ca2+/ calmodulin kinase II and protein kinase C in mouse hippocampus. J Pharmacol Exp Ther. 2008;326:127-134. (Pubitemid 351872142)
8. Shioda N, Yamamoto Y, Han F, Moriguchi S, Yamaguchi Y, Hino M, et al. A novel cognitive enhancer, ST101/ST101, promotes hippocampal neurogenesis and ameliorates depressive behavior in olfactory bulbectomized mice. J Pharmacol Exp Ther. 2010;333:43-50.
9. Green KN, Khashwji H, Estrada T, Laferla FM. ST101 induces a novel 17kDa APP cleavage that precludes Aβ generation in vivo. Ann Neurol. 2011;69:831-844.
10. Moriguchi S, Shioda N, Yamamoto Y, Tagashira H, Fukunaga K. The T-type voltage-gated calcium channel as a molecular target of the novel cognitive enhancer ST101 Enhancement of longterm potentiation and CaMKII autophosphorylation in rat cortical slices. J Neurochem. 2012;121:44-53.
11. Paxinos G, Franklin KBJ. The mouse brain in stereotaxic coordinates. 2nd ed. San Diego: Academic Press; 2001.
12. Allami N, Javadi-Paydar M, Rayatnia F, Sehhat K, Rahimian R, Norouzi A, et al. Suppression of nitric oxide synthesis by L-NAME reverses the beneficial effects of pioglitazone on scopolamine-induced memory impairment in mice. Eur J Pharmacol. 2011;650:240-248.
13. Han F, Shioda N, Moriguchi S, Qin ZH, Fukunaga K. Downregulation of glutamate transporters is associated with elevation in extracellular glutamate concentration following rat microsphere embolism. Neurosci Lett. 2008;430:275-280.
14. Fukunaga K, Goto S, Miyamoto E. Immunohistochemical localization of Ca2+/calmodulin-dependent protein kinase II in rat brain and various tissues. J Neurochem. 1988;51:1070-1078.
15. Fukunaga K, Soderling TR, Miyamoto E. Activation of Ca2+/calmodulin- dependent protein kinase II and protein kinase C by glutamate in cultured rat hippocampal neurons. J Biol Chem. 1992;267:22527-22533.
16. Ennaceur A, Aggleton JP. The effects of neurotoxic lesions of the perirhinal cortex combined to fornix transection on object recognition memory in the rat. Behav Brain Res. 1997;88:181- 193. (Pubitemid 27498504)
17. Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology. 1985;85:367-370. (Pubitemid 15123115)
18. Bisagno V, Raineri M, Peskin V, Wikinski SI, Uchitel OD, Llinás RR, et al. Effects of T-type calcium channel blockers on cocaineinduced hyperlocomotion and thalamocortical GABAergic abnormalities in mice. Psychopharmacology. 2010;212:205-214.
19. Todorovic SM, Meyenburg A, Jevtovic-Todorovic V. Mechanical and thermal antinociception in rat following systematic administration of mibefradil, a T-type calcium channel blocker. Brain Res. 2002;951:336-340. (Pubitemid 35248032)
20. Miwa H, Koh J, Kajimoto Y, Kondo T. Effects of T-type calcium channel blockers on parkinsonian tremor model in rats. Pharm Biochem Behav. 2011;97:656-659.
21. Mishra SK, Hermsmeyer K. Selective inhibition of T-type Ca2+ channels by Ro 40-5967. Circ Res. 1994;75:144-148.
22. Moriguchi S, Han F, Nakagawasai O, Tadano T, Fukunaga K. Decreased calcium/calmodulin-dependent protein kinase II and protein kinase C activities mediate impairment of hippocampal long-term potentiation in the olfactory bulbectomized mice. J Neurochem. 2006;97:22-29.
23. Yoshimura H, Gomita Y, Ueki S. Changes in acetylcholine content in rat brain after bilateral olfactory bulbectomy in relation to mouse-killing behavior. Pharmacol Biochem Behav. 1974;2:703-705.
24. Anderson MP, Mochizuki T, Xie J, Fischler W, Manger JP, Talley EM, et al. Thalamic Cav3.1 T-type Ca2+ channel plays a crucial role in stabilizing sleep. Proc Natl Acad Sci U S A. 2005;102:1743-1748. (Pubitemid 40209238)
25. Ertel SI, Clozel JP. Mibefradil (Ro 40-5967): the first selective T-type Ca2+ channel blocker. Expert Opin Investig Drugs. 1997; 6:569-582. (Pubitemid 27225534)
26. Nakajima A, Yamakuni T, Haraguchi M, Omae N, Song SY, Kato C, et al. Nobiletin, a citrus flavonoid that improves memory impairment, rescues bulbectomy-induced cholinergic neurodegeneration in mice. J Pharmacol Sci. 2007;105:122-126. (Pubitemid 47463532)
27. Nilsson L, Nordberg A, Hardy NJ, Wester P, Winblad B. Physostigumine restores 3H-Acetylcholine efflux from Alzheimer brain slices to normal level. J Neural Transm. 1986;67:275-285. (Pubitemid 17184853)
28. Talley EM, Cribbs LL, Lee JH, Daud A, Perez-Reyes E, Bayliss DA. Differential distribution of three members of a gene family encoding low voltage-Activated (T-type) calcium channels. J Neurosci. 1999;19:1895-1911. (Pubitemid 29133368)
29. Chen CC, Shen JW, Chung NC, Min MY, Cheng SJ, Liu IY. Retrieval of Context-Associated Memory is Dependent on the Ca(v)3.2 T-Type Calcium Channel. PLoS One. 2012;7:e29384.
30. Altier C, Zamponi GW. Targeting Ca2+ channels to treat pain: T-type versus N-type. Trends Pharmacol Sci. 2004;25:465-470. (Pubitemid 39149702)
31. McKay BE, McRory JE, Molineux ML, Hamid J, Snutch TP, Zamponi GW, et al. CaV3 T-type calcium channel isoforms differentially distribute to somatic and dendritic compartments in rat central neurons. Eur J Neurosci. 2006;24:2581-2594. (Pubitemid 44726770)
32. Katz B, Miledi R. The effect of calcium on acetylcholine release from motor nerve terminals. Proc R Soc Lond B Biol Sci. 1965;161:496-503.
33. Zhu G, Okada M, Murakami T, Kawata Y, Kamata A, Kaneko S. Interaction between carbamazepine, zonisamide and voltagesensitive Ca2+ channel on acetylcholine release in rat frontal cortex. Epilepsy Res. 2002;49:49-60. (Pubitemid 34304206)
34. McGehee DS, Heath MJ, Gelber S, Devay P, Role LW. Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science. 1995;269:1692-1696.
35. Tsuneki H, Klink R, Léna C, Korn H, Changeux JP. Calcium mobilization elicited by two types of nicotinic acetylcholine receptors in mouse substantia nigra pars compacta. Eur J Neurosci. 2000;12:2475-2485. (Pubitemid 30497042)
36. Chemin J, Traboulsie A, Lory P. Molecular pathways underlying the modulation of T-type calcium channels by neurotransmitters and hormones. Cell Calcium. 2006;40:121-134. (Pubitemid 43942297)
37. Hildebrand ME, Isope P, Miyazaki T, Nakaya T, Garcia E, Feltz A, et al. Functional coupling between mGluR1 and Cav3.1 T-type calcium channels contributes to parallel fiber-induced fast calcium signaling within Purkinje cell dendritic spines. J Neurosci. 2009;29:9668-9682.
38. Kim D, Song I, Keum S, Lee T, Jeong MJ, Kim SS, et al. Lack of the burst firing of thalamocortical relay neurons and resistance to absence seizures in mice lacking α1G T-type Ca2+ channels. Neuron. 2001;31:35-45. (Pubitemid 32757087)
39. Tang AH, Karson MA, Nagode DA, McIntosh JM, Uebele VN, Renger JJ, et al. Nerve terminal nicotinic acetylcholine receptors initiate quantal GABA release from perisomatic interneurons by activating axonal T-type (Cav3) Ca2+ channels and Ca2+ release from stores. J Neurosci. 2011;31:13546-13561.